Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase AUA Poster

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon May 01, 2023 1:16pm

118 Views

Post# 35423148

RE:RE:RE:RE:Theralase AUA Poster

There is some ambiguity in the way the Raw Data is presented on the Swimmer's plot. I am hoping the Management has good reasons to present facts in a certain way that is acceptable to FDA. Ultimately that is our common objective. Going back and forth on this is only hurting the Stock price today. I think, if we choose to wait for the AUA poster and discussion data and comments from the Press and other particioants, we will actually learn something more valuable to all of us.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market